Compare SEZL & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEZL | HAE |
|---|---|---|
| Founded | 2016 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.8B |
| IPO Year | 2023 | 1996 |
| Metric | SEZL | HAE |
|---|---|---|
| Price | $118.15 | $103.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $109.33 | $84.13 |
| AVG Volume (30 Days) | 769.9K | ★ 781.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.64 | 0.72 |
| Revenue | $450,279,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $30.30 | N/A |
| Revenue Next Year | $24.79 | $5.23 |
| P/E Ratio | ★ $43.38 | $141.60 |
| Revenue Growth | ★ 66.08 | N/A |
| 52 Week Low | $49.50 | $47.32 |
| 52 Week High | $195.71 | $109.57 |
| Indicator | SEZL | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 64.70 |
| Support Level | $108.51 | $79.52 |
| Resistance Level | $136.59 | $109.57 |
| Average True Range (ATR) | 5.08 | 2.51 |
| MACD | 0.28 | -0.74 |
| Stochastic Oscillator | 8.44 | 65.43 |
Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.